{"id":"https://openalex.org/W2157402102","doi":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","title":"Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin","display_name":"Pharmacokinetic Interactions between Nelfinavir and 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors Atorvastatin and Simvastatin","alternate_titles":[],"publication_year":2001,"publication_date":"2001-12-01","ids":{"openalex":"https://openalex.org/W2157402102","doi":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","mag":"2157402102","pmid":"https://pubmed.ncbi.nlm.nih.gov/11709322","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/90851"},"language":"en","primary_location":{"id":"doi:10.1128/aac.45.12.3445-3450.2001","doi":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2157402102"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://europepmc.org/pmc/articles/PMC90851","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5109994152","display_name":"Poe\u2010Hirr Hsyu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Poe-Hirr Hsyu","raw_affiliation_strings":["<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057177666","display_name":"Melissa D. Schultz-Smith","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Melissa D. Schultz-Smith","raw_affiliation_strings":["<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086942033","display_name":"James H. Lillibridge","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James H. Lillibridge","raw_affiliation_strings":["<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108110360","display_name":"Ronald H. Lewis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ronald H. Lewis","raw_affiliation_strings":["<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105523204","display_name":"Bradley M. Kerr","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bradley M. Kerr","raw_affiliation_strings":["<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"<!--label omitted: 1-->Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]},{"raw_affiliation_string":"Agouron Pharmaceuticals Inc., A Pfizer Company, La Jolla, California","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":5.7142,"has_fulltext":false,"cited_by_count":157,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96978923,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"45","issue":"12","first_page":"3445","last_page":"3450"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9247999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9247999787330627,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.019700000062584877,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.019300000742077827,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nelfinavir","display_name":"nelfinavir","score":0.9980000257492065},{"id":"https://openalex.org/keywords/atorvastatin","display_name":"atorvastatin","score":0.9950000047683716},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.968999981880188},{"id":"https://openalex.org/keywords/protease-inhibitors","display_name":"protease inhibitors","score":0.8629999756813049},{"id":"https://openalex.org/keywords/drug-drug-interactions","display_name":"drug-drug interactions","score":0.8289999961853027},{"id":"https://openalex.org/keywords/cyp3a4-inhibition","display_name":"CYP3A4 inhibition","score":0.8759999871253967},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8740000128746033},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"antiretroviral therapy","score":0.8550000190734863}],"concepts":[{"id":"https://openalex.org/C2781160516","wikidata":"https://www.wikidata.org/wiki/Q423366","display_name":"Nelfinavir","level":5,"score":0.9142991304397583},{"id":"https://openalex.org/C2776329913","wikidata":"https://www.wikidata.org/wiki/Q670131","display_name":"Simvastatin","level":2,"score":0.9089210033416748},{"id":"https://openalex.org/C2777482532","wikidata":"https://www.wikidata.org/wiki/Q668093","display_name":"Atorvastatin","level":2,"score":0.8650989532470703},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.825620174407959},{"id":"https://openalex.org/C2777320049","wikidata":"https://www.wikidata.org/wiki/Q2989497","display_name":"Hydroxymethylglutaryl-CoA reductase","level":5,"score":0.620693027973175},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6184847950935364},{"id":"https://openalex.org/C134651460","wikidata":"https://www.wikidata.org/wiki/Q3100717","display_name":"Reductase","level":3,"score":0.5685102939605713},{"id":"https://openalex.org/C104950815","wikidata":"https://www.wikidata.org/wiki/Q415607","display_name":"HMG-CoA reductase","level":4,"score":0.5431872606277466},{"id":"https://openalex.org/C97320921","wikidata":"https://www.wikidata.org/wiki/Q718753","display_name":"Drug interaction","level":3,"score":0.504447340965271},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.42724573612213135},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.425632506608963},{"id":"https://openalex.org/C109650736","wikidata":"https://www.wikidata.org/wiki/Q424440","display_name":"CYP3A4","level":4,"score":0.41145792603492737},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4110102355480194},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.38113003969192505},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.2979584336280823},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.2215239703655243},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21158969402313232},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.18911784887313843},{"id":"https://openalex.org/C526171541","wikidata":"https://www.wikidata.org/wiki/Q407693","display_name":"Cytochrome P450","level":3,"score":0.12959685921669006},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.07125324010848999},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.07094308733940125},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.054051101207733154},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.0}],"mesh":[{"descriptor_ui":"D000069059","descriptor_name":"Atorvastatin","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004347","descriptor_name":"Drug Interactions","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006538","descriptor_name":"Heptanoic Acids","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008055","descriptor_name":"Lipids","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019821","descriptor_name":"Simvastatin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D019888","descriptor_name":"Nelfinavir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1128/aac.45.12.3445-3450.2001","doi":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","is_oa":false,"landing_page_url":"https://doi.org/10.1128/aac.45.12.3445-3450.2001","pdf_url":null,"source":{"id":"https://openalex.org/S47215897","display_name":"Antimicrobial Agents and Chemotherapy","issn_l":"0066-4804","issn":["0066-4804","1070-6283","1098-6596"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320263","host_organization_name":"American Society for Microbiology","host_organization_lineage":["https://openalex.org/P4310320263"],"host_organization_lineage_names":["American Society for Microbiology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial Agents and Chemotherapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:192786","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC90851","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:90851","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC90851/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrob Agents Chemother","raw_type":"Text"},{"id":"pmid:11709322","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11709322","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antimicrobial agents and chemotherapy","raw_type":"Clinical Trial"}],"best_oa_location":{"id":"pmh:oai:europepmc.org:192786","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC90851","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9940000176429749}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1581747141","https://openalex.org/W1601678499","https://openalex.org/W1971242943","https://openalex.org/W1978530024","https://openalex.org/W1979536626","https://openalex.org/W1986838867","https://openalex.org/W1996148649","https://openalex.org/W2014859893","https://openalex.org/W2023294622","https://openalex.org/W2028917349","https://openalex.org/W2029877539","https://openalex.org/W2032890774","https://openalex.org/W2044405747","https://openalex.org/W2059654642","https://openalex.org/W2061864878","https://openalex.org/W2080083635","https://openalex.org/W2087015670","https://openalex.org/W2099509337","https://openalex.org/W2131403498","https://openalex.org/W2142144836","https://openalex.org/W2149568397","https://openalex.org/W2155608888","https://openalex.org/W2318289184","https://openalex.org/W2329393410","https://openalex.org/W2411506436","https://openalex.org/W2418611981"],"related_works":["https://openalex.org/W1988708673","https://openalex.org/W1977355295","https://openalex.org/W1967204625","https://openalex.org/W2064049784","https://openalex.org/W35427688","https://openalex.org/W2118964190","https://openalex.org/W2517970972","https://openalex.org/W2039688545","https://openalex.org/W1965283912"],"abstract_inverted_index":{"3-Hydroxy-3-methylglutaryl":[0],"coenzyme":[1],"A":[2],"(HMG-CoA)":[3],"reductase":[4,37,93],"inhibitors":[5,38,41,56,59],"are":[6,15,42,57],"effective":[7],"agents":[8],"in":[9,98],"lowering":[10],"cholesterol":[11],"and":[12,14,39,90,96,148,174,182,189],"triglycerides":[13],"being":[16],"used":[17,222],"by":[18,44],"human":[19],"immunodeficiency":[20],"virus-positive":[21],"patients":[22],"to":[23,81,139,200],"treat":[24],"the":[25,45,83,121,126,158,162,175,184,190,202],"lipid":[26],"elevation":[27],"that":[28,209],"may":[29,70],"be":[30,216,221],"associated":[31],"with":[32,213,223,225],"antiretroviral":[33],"therapy.":[34],"Many":[35],"HMG-CoA":[36,92],"protease":[40,55,88],"metabolized":[43],"same":[46],"cytochrome":[47],"P450":[48],"enzyme":[49],"3A4":[50],"(CYP3A4).":[51],"In":[52],"addition,":[53],"many":[54],"potent":[58],"of":[60,64,68,125,171,179,186,192,204,211],"CYP3A4.":[61],"Therefore,":[62],"coadministration":[63,210],"these":[65],"two":[66,91],"classes":[67],"drugs":[69,152],"cause":[71],"significant":[72],"drug":[73],"interactions.":[74],"This":[75],"open-label,":[76],"multiple-dose":[77],"study":[78,151],"was":[79,134,143],"performed":[80,144],"determine":[82],"interactions":[84],"between":[85],"nelfinavir,":[86],"a":[87,111,118,132],"inhibitor,":[89],"inhibitors,":[94],"atorvastatin":[95,106,172,180,196,219],"simvastatin,":[97],"healthy":[99,102],"volunteers.":[100],"Thirty-two":[101],"subjects":[103],"received":[104],"either":[105],"calcium":[107],"(10":[108],"mg":[109,116,130],"once":[110,117],"day)":[112,119,133],"or":[113],"simvastatin":[114,187,193,198,212],"(20":[115],"for":[120],"first":[122],"14":[123,147],"days":[124,137,146],"study.":[127],"Nelfinavir":[128,156],"(1,250":[129],"twice":[131],"added":[135],"on":[136,145],"15":[138],"28.":[140,149],"Pharmacokinetic":[141],"assessment":[142],"The":[150],"were":[153],"well":[154],"tolerated.":[155],"increased":[157,183],"steady-state":[159],"area":[160],"under":[161],"plasma":[163],"concentration-time":[164],"curve":[165],"during":[166],"one":[167],"dosing":[168],"period":[169],"(AUC(tau))":[170],"74%":[173],"maximum":[176],"concentration":[177],"(C(max))":[178],"122%":[181],"AUC(tau)":[185],"505%":[188],"C(max)":[191],"517%.":[194],"Neither":[195],"nor":[197],"appeared":[199],"alter":[201],"pharmacokinetics":[203],"nelfinavir.":[205],"It":[206],"is":[207],"recommended":[208],"nelfinavir":[214,224],"should":[215,220],"avoided,":[217],"whereas":[218],"caution.":[226]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2157402102","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-22T12:46:00.618207","created_date":"2016-06-24T00:00:00"}
